Refine by MP, party, committee, province, or result type.

Results 1-15 of 34
Sorted by relevance | Sort by date: newest first / oldest first

Public Accounts committee  I could actually provide further guidance on this and mention the fact that in 2021 in Canada, Pfizer alone delivered over 55 million doses, which is way above what was initially in the contract. In other words, Pfizer has been able to deliver more vaccines faster in Canada than what was initially planned in the contract.

March 23rd, 2023Committee meeting

Fabien Paquette

Public Accounts committee  Thank you, Najah. Thank you for the question. The actual first agreement that was signed and communicated was in August of 2020. That was the first agreement that Pfizer signed. That was an early agreement to actually establish a basis for a more detailed agreement later on. That was basically a couple of weeks after the U.S. and among the first in the world after the U.S.

March 23rd, 2023Committee meeting

Fabien Paquette

Public Accounts committee  If I may speak on this one, I could clearly say that we never worked with McKinsey related to any contracts for vaccines or any other contracts in Canada.

March 23rd, 2023Committee meeting

Fabien Paquette

Public Accounts committee  I'm not aware of any contract that we have with McKinsey outside of what we can do in my area, which is for vaccines.

March 23rd, 2023Committee meeting

Fabien Paquette

Public Accounts committee  I'm not aware of whether we've worked, or not, with McKinsey. I know that in vaccines we haven't for the contracts. That's for sure.

March 23rd, 2023Committee meeting

Fabien Paquette

Foreign Affairs committee  Thank you for the question. We are investing significantly in looking at further options. We have Paxlovid, as you mentioned, which is an important treatment that is available right now around the world. Of course, we need to continue the research. We need to look at other studies to see what the impact of Paxlovid will be on long COVID.

April 25th, 2022Committee meeting

Fabien Paquette

Foreign Affairs committee  Absolutely. I think those were two fundamental elements that Kiersten talked about. Education is fundamental, and also making sure that immunizers have the education and capability to provide the vaccines to their population.

April 25th, 2022Committee meeting

Fabien Paquette

Foreign Affairs committee  At this point in time, we have absolutely no issues with production. We can still supply the vaccines around the world.

April 25th, 2022Committee meeting

Fabien Paquette

Foreign Affairs committee  Well, it would depend on the cost of the meal in that country, but as you can see, I would say from what we've seen, generally speaking, that the cost of vaccines—

April 25th, 2022Committee meeting

Fabien Paquette

Foreign Affairs committee  Depending on the country, they would be in tier one, tier two, or tier three pricing, so—

April 25th, 2022Committee meeting

Fabien Paquette

Foreign Affairs committee  Well, not exactly the same price, but I would say it would be the same ballpark figure, as I don't have access to other countries' prices. That's what I understood is the case.

April 25th, 2022Committee meeting

Fabien Paquette

Foreign Affairs committee  As a tier one country, Canada has paid a price in the range of tier one countries.

April 25th, 2022Committee meeting

Fabien Paquette

Foreign Affairs committee  As you can realize here, there have been some confidentiality components in our agreement with the Government of Canada—

April 25th, 2022Committee meeting

Fabien Paquette

Foreign Affairs committee  —and as such, I'm not allowed to disclose any prices.

April 25th, 2022Committee meeting

Fabien Paquette

Foreign Affairs committee  Yes, absolutely. No, they just needed to make sure they.... We need to keep in mind that when Canada started to receive vaccines, the priority of the public health agencies across all provinces was to deploy the vaccines locally. That said, at any time there was an opportunity for Canada to engage with us to ensure that there would be a realignment of doses to lower- or middle-income countries.

April 25th, 2022Committee meeting

Fabien Paquette